Wednesday, February 04, 2009 4:30:08 AM
BMRN:
You should follow the BMRN board its almost like family there
#msg-35292526
I never put much value into it and after the prior failure I think the PAD had very little chance (the wildcard being if the Vitamin-C subset had a benefit). So obviously I still think the stock cheap
#msg-35291407
I am wondering if they now consider doing something with Pompe on their own
#msg-35295986
After more insomnia I got to thinking another possibility is some sort of collaboration with Amicus (the stock seems to be on a little move of late) which indicated encouraging in vitro results (not sure how far their animal data is) combining their chaperone to stabilize Myozyme. I am no scientist but I would think this may be applicable (perhaps not to the same degree) to enzymes made with a different cell line?
You should follow the BMRN board its almost like family there
#msg-35292526
I never put much value into it and after the prior failure I think the PAD had very little chance (the wildcard being if the Vitamin-C subset had a benefit). So obviously I still think the stock cheap
#msg-35291407
I am wondering if they now consider doing something with Pompe on their own
#msg-35295986
After more insomnia I got to thinking another possibility is some sort of collaboration with Amicus (the stock seems to be on a little move of late) which indicated encouraging in vitro results (not sure how far their animal data is) combining their chaperone to stabilize Myozyme. I am no scientist but I would think this may be applicable (perhaps not to the same degree) to enzymes made with a different cell line?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
